←
Cellectis1,096 posts
Cellectis avatar

Cellectis

@cellectis

Cellectis is a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment.

◷ Joined October 2009▧ 384 Photos and videos
Cellectis avatar
Cellectis@cellectis·Oct 27

Today at the European Society of Gene and Cell Therapy, we are presenting preclinical data on .HEAL-101, our in vivo base editing product candidate targeting APOC3 for severe hypertriglyceridemia. To read the full press release: shorturl.at/ZXMo6 #ESGCT2026

Post attachment
Cellectis avatar
Cellectis@cellectis·Oct 21

Et si une seule administration permettait de traiter à la source certaines maladies cardiométaboliques sévères ? André Choulika était l'invité de @bfmbusiness pour échanger sur les nouvelles perspectives ouvertes par l'édition du génome: tinyurl.com/m8fwzhcm

Post attachment
Cellectis avatar
Cellectis@cellectis·Oct 15

Pourquoi arrêter un programme clinique qui venait d’obtenir le statut RMAT de la FDA ? André Choulika répond dans Le Journal des Biotechs de @Boursorama. Il y explique la transformation de Cellectis en société d’édition du génome in vivo >> shorturl.at/cbu8n

Post attachment
Cellectis avatar
Cellectis@cellectis·Jun 11

Today at #EHA2026, we shared final Ph1 results from BALLI-01, evaluating lasme-cel in patients with r/r B-ALL. *100% ORR in the target Ph2 population (n=7) *All responding patients proceeded to transplant *Manageable safety profile Full press release: cellectis.com/en/press/celle…

Post attachment
Cellectis avatar
Cellectis@cellectis·Jun 9

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL. To read the press release: cellectis.com/en/press/celle…

0:06